CMS Open Payments · Program Year 2024
Surgical Theater. Inc.
Surgical Theater. Inc. reported $257,687.14 across General Payments, Research, and Ownership to 131 physicians and teaching hospitals across 135 transactions.
- $257.7K Above-median payer
- All-tracks total
- 135 Below-median volume
- Transactions
- 131 Below-median reach
- Recipients
- −$29.4K
- General Payments vs PY2023
Surgical Theater. Inc. reported $257,687.14 across all CMS Open Payments tracks (General + Research + Ownership) to 131 physicians and teaching hospitals in Program Year 2024 - ranking #929 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $199,938.14, averaging $2.0K per recipient.
How Surgical Theater. Inc.'s $257.7K all-tracks total breaks down
Surgical Theater. Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
28/100
Total payments
F
12/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer surgical-theater-inc Surgical Theater. Inc.
$257.7K · #929/1,925 · 0.0% industry · PY2024
- TOT $257.7K
- RANK #929
- SHARE 0.0%
- TXN 135
- RCP 131
- CAT 6
- GEN $199.9K
- ΔGEN −$29.4K
- TOP1 58.0%
- PY 2024
Volume peers
Nearest volume peer: Ascensia Diabetes Care Us Inc. ($258.2K)
Surgical Theater. Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Surgical Theater. Inc.'s CMS-reported General Payments decreased by $29.4K (−12.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SURGICAL THEATER. INC.PY2023: SURGICAL THEATER. INC.PY2024: Surgical Theater. Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $229,383.17
- PY2024
- $199,938.14
What the Data Shows for Surgical Theater. Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Surgical Theater. Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 6-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $113.2K, accounting for 56.6% of this company's General Payments and 2 transactions.
General Payment Breakdown by Type
Across 6 types of general payments, Surgical Theater. Inc.'s largest category was "Consulting Fee" at $113.2K - 56.6% of General Payments.
Surgical Theater. Inc. reports 6 general-payment categories - the top three are Consulting Fee (56.6%), Gift (27.0%), and Travel and Lodging (8.1%). The remaining 3 categories make up 8.2% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Surgical Theater. Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $113.2K | 2 | 56.6% |
| Gift | $54.0K | 2 | 27.0% |
| Travel and Lodging | $16.3K | 24 | 8.1% |
| Food and Beverage | $11.4K | 97 | 5.7% |
| Compensation for Services Other Than Consulting | $4.0K | 5 | 2.0% |
| Royalty or License | $1.1K | 1 | 0.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $183,027.56 (91.5%) of $199,938.14 in this company's General Payments records across 52 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Surgical Theater. Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Robert Louis Mr
$115,937.29 across 16 reported transactions
- 2
Cedars-Sinai Medical Center
$42,000.00 across 1 reported transactions
- 3
Thomas Jefferson Univ. Hospital
$12,000.00 across 1 reported transactions
- 4
Walter Jean Mr
$7,891.56 across 11 reported transactions
- 5
Gregory Poulter Mr
$5,198.71 across 13 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Surgical Theater. Inc. ranks #929 of 1,925 by total payments (top 48% by spend) but is notably more concentrated than that alone would suggest -- #458 of 1,838 by HHI (top 25% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- B. Braun Melsungen AG : $165.4K total payments, HHI 3974
- Dynavax Technologies Corporation : $446.2K total payments, HHI 3923
- Materialise USA LLC : $273.65 total payments, HHI 3922
- Rare Disease Therapeutics, Inc. : $5.6K total payments, HHI 3906
- OraSure Technologies Inc. : $211.4K total payments, HHI 3885
- Gotham Surgical Solutions & Devices, Inc. : $164.9K total payments, HHI 3883
- Surgical Theater. Inc. (this company) : $199.9K total payments, HHI 3868
- Helsinn Healthcare SA : $296.6K total payments, HHI 3863
- 4DMedical USA Inc : $233.5K total payments, HHI 3861
- SCA Pharmaceuticals, LLC : $806.08 total payments, HHI 3852
- Oculus Surgical Inc. : $127.1K total payments, HHI 3851
- Sc Medica : $25.3K total payments, HHI 3839
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Surgical Theater. Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Surgical Theater. Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Surgical Theater. Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Surgical Information Sciences, Inc.
FUJIFILM Sonosite, Inc.
Qapel Medical Inc
Urgo Medical North America, LLC
Ossur Americas, Inc.
Put this to use
Surgical Theater. Inc. ranks #929 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Surgical Theater. Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.